TRCT
ZBH icon

Tower Research Capital (TRC)’s Zimmer Biomet ZBH Stock Holding History

Tower Research Capital (TRC)’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$194K Sell
2,150
-1,969
-48% -$181K 0.01% 1643
2025
Q4 		$370K Buy
4,119
+1,333
+48% +$126K 0.01% 1014
2025
Q3 		$274K Buy
2,786
+568
+26% +$56.3K 0.01% 1238
2025
Q2 		$202K Sell
2,218
-3,094
-58% -$299K 0.01% 1766
2025
Q1 		$601K Sell
5,312
-11,146
-68% -$1.19M 0.02% 733
2024
Q4 		$1.74M Buy
16,458
+8,691
+112% +$933K 0.03% 409
2024
Q3 		$838K Sell
7,767
-412
-5% -$45K 0.02% 621
2024
Q2 		$888K Buy
8,179
+4,989
+156% +$588K 0.02% 856
2024
Q1 		$421K Sell
3,190
-23,387
-88% -$2.92M 0.01% 961
2023
Q4 		$3.23M Buy
26,577
+18,019
+211% +$2.01M 0.04% 373
2023
Q3 		$960K Buy
8,558
+662
+8% +$84.1K 0.03% 559
2023
Q2 		$1.15M Buy
7,896
+3,509
+80% +$477K 0.04% 429
2023
Q1 		$567K Buy
4,387
+1,060
+32% +$133K 0.02% 751
2022
Q4 		$424K Sell
3,327
-14,367
-81% -$1.67M 0.02% 793
2022
Q3 		$1.85M Buy
17,694
+4,669
+36% +$512K 0.03% 451
2022
Q2 		$1.37M Sell
13,025
-17,228
-57% -$2.04M 0.03% 529
2022
Q1 		$3.87M Buy
30,253
+15,511
+105% +$1.87M 0.04% 375
2021
Q4 		$1.82M Buy
14,742
+11,353
+335% +$1.49M 0.03% 447
2021
Q3 		$482K Sell
3,389
-1,252
-27% -$184K 0.01% 1018
2021
Q2 		$724K Sell
4,641
-20,417
-81% -$3.31M 0.02% 898
2021
Q1 		$3.89M Buy
25,058
+15,203
+154% +$2.35M 0.07% 273
2020
Q4 		$1.47M Buy
9,855
+4,226
+75% +$597K 0.05% 331
2020
Q3 		$744K Buy
5,629
+1,105
+24% +$144K 0.01% 1269
2020
Q2 		$524K Buy
+4,524
New +$521K 0.02% 992
2019
Q4 		– Sell
-4,902
Closed -$653K – 4486
2019
Q3 		$653K Buy
4,902
+4,842
+8,070% +$625K 0.04% 465
2019
Q2 		$7K Sell
60
-3,902
-98% -$457K ﹤0.01% 2797
2019
Q1 		$491K Sell
3,962
-4,351
-52% -$494K 0.03% 611
2018
Q4 		$837K Buy
8,313
+8,018
+2,718% +$902K 0.06% 305
2018
Q3 		$38K Sell
295
-4,607
-94% -$548K ﹤0.01% 1937
2018
Q2 		$530K Buy
4,902
+4,216
+615% +$459K 0.03% 622
2018
Q1 		$73K Sell
686
-1,627
-70% -$189K 0.01% 1460
2017
Q4 		$271K Buy
+2,313
New +$262K 0.04% 466
2017
Q3 		– Sell
-50
Closed -$6K – 4202
2017
Q2 		$6K Sell
50
-120
-71% -$14.2K ﹤0.01% 1922
2017
Q1 		$20K Sell
170
-5,538
-97% -$628K ﹤0.01% 1311
2016
Q4 		$572K Buy
+5,708
New +$612K 0.06% 318
2016
Q3 		– Sell
-943
Closed -$117K – 4562
2016
Q2 		$110K Buy
943
+634
+205% +$71.8K 0.01% 1040
2016
Q1 		$32K Buy
309
+206
+200% +$19.9K ﹤0.01% 1029
2015
Q4 		$10K Buy
+103
New +$10.1K ﹤0.01% 2158
2015
Q3 		– Sell
-4,954
Closed -$525K – 4881
2015
Q2 		$525K Buy
+4,954
New +$548K 0.05% 137
2015
Q1 		– Sell
-345
Closed -$38K – 5011
2014
Q4 		$38K Sell
345
-6,613
-95% -$697K ﹤0.01% 1194
2014
Q3 		$679K Buy
6,958
+6,762
+3,450% +$665K 0.08% 201
2014
Q2 		$20K Sell
196
-2,650
-93% -$259K ﹤0.01% 1851
2014
Q1 		$261K Buy
2,846
+1,892
+198% +$174K 0.03% 339
2013
Q4 		$86K Sell
954
-1,218
-56% -$105K 0.01% 955
2013
Q3 		$173K Buy
2,172
+1,646
+313% +$130K 0.02% 851
2013
Q2 		$38K Buy
+526
New +$39.3K ﹤0.01% 1148

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tower Research Capital (TRC)'s ZBH Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Zimmer Biomet (ZBH) stake by 48% in Q1 2026, selling an estimated $181K and leaving 2,150 shares worth $194K. The position accounts for 0.01% of the portfolio, ranked #1643.

Tower Research Capital (TRC) first reported a position in ZBH in Q2 2013 and has held it in 46 quarters since. The position peaked at $3.89M in Q1 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Tower Research Capital (TRC) held 2,150 shares of Zimmer Biomet worth $194K as of Q1 2026.
  • Tower Research Capital (TRC) sold 1,969 Zimmer Biomet shares in Q1 2026, an estimated $181K.
  • Zimmer Biomet made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1643 holding.
  • Tower Research Capital (TRC) first reported a position in Zimmer Biomet in Q2 2013 and has held it in 46 quarters since.
  • Tower Research Capital (TRC)'s Zimmer Biomet position peaked at $3.89M in Q1 2021.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.